Skip to main content
American Journal of Public Health logoLink to American Journal of Public Health
. 1998 Apr;88(4):630–636. doi: 10.2105/ajph.88.4.630

Modeling all-cause mortality: projections of the impact of smoking cessation based on the NHEFS. NHANES I Epidemiologic Follow-up Study.

L B Russell 1, J L Carson 1, W C Taylor 1, E Milan 1, A Dey 1, R Jagannathan 1
PMCID: PMC1508449  PMID: 9551006

Abstract

OBJECTIVES: A model that relates clinical risk factors to subsequent mortality was used to simulate the impact of smoking cessation. METHODS: Survivor functions derived from multivariate hazard regressions fitted to data from the first National Health and Nutrition Examination Survey (NHANES I) Epidemiologic Followup Study, a longitudinal survey of a representative sample of US adults, were used to project deaths from all causes. RESULTS: Validation tests showed that the hazard regressions agreed with the risk relationships reported by others, that projected deaths for baseline risk factors closely matched observed mortality, and that the projections attributed deaths to the appropriate levels of important risk factors. Projections of the impact of smoking cessation showed that the number of cumulative deaths would be 15% lower after 5 years and 11% lower after 20 years. CONCLUSIONS: The model produced realistic projections of the effects of risk factor modification on subsequent mortality in adults, Comparison of the projections for smoking cessation with estimates of the risk attributable to smoking published by the Centers for Disease Control and Prevention suggests that cessation could capture most of the benefit possible from eliminating smoking.

Full text

PDF
630

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Goldman L., Weinstein M. C., Williams L. W. Relative impact of targeted versus populationwide cholesterol interventions on the incidence of coronary heart disease. Projections of the Coronary Heart Disease Policy Model. Circulation. 1989 Aug;80(2):254–260. doi: 10.1161/01.cir.80.2.254. [DOI] [PubMed] [Google Scholar]
  2. Grover S. A., Abrahamowicz M., Joseph L., Brewer C., Coupal L., Suissa S. The benefits of treating hyperlipidemia to prevent coronary heart disease. Estimating changes in life expectancy and morbidity. JAMA. 1992 Feb 12;267(6):816–822. [PubMed] [Google Scholar]
  3. Stevenson C. E. Statistical models for cancer screening. Stat Methods Med Res. 1995 Mar;4(1):18–32. doi: 10.1177/096228029500400103. [DOI] [PubMed] [Google Scholar]
  4. Taylor W. C., Pass T. M., Shepard D. S., Komaroff A. L. Cholesterol reduction and life expectancy. A model incorporating multiple risk factors. Ann Intern Med. 1987 Apr;106(4):605–614. doi: 10.7326/0003-4819-106-4-605. [DOI] [PubMed] [Google Scholar]
  5. Tsevat J., Weinstein M. C., Williams L. W., Tosteson A. N., Goldman L. Expected gains in life expectancy from various coronary heart disease risk factor modifications. Circulation. 1991 Apr;83(4):1194–1201. doi: 10.1161/01.cir.83.4.1194. [DOI] [PubMed] [Google Scholar]
  6. Weinstein M. C., Coxson P. G., Williams L. W., Pass T. M., Stason W. B., Goldman L. Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model. Am J Public Health. 1987 Nov;77(11):1417–1426. doi: 10.2105/ajph.77.11.1417. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES